Get Our Free Research EmailWeekly News and Analysis about the Orthopedic and Dental Industry.
privacy policy · sample email
Conference Calendar
|
Orthopedic and Dental Industry News
|
| Price | 52-Week High |
% Decline | TTM PE | |
| BMET | 35.03 | 49.64 | 42% | 22.63 |
| ENMC | 4.78 | 7.18 | 50% | 37.94 |
| EXAC | 14.8 | 21.15 | 43% | 25.83 |
| SNN | 42.65 | 53.79 | 26% | 29.15 |
| SYK | 49.66 | 56.32 | 13% | 38.17 |
| ZMH | 68.46 | 89.1 | 30% | 24.63 |
| WMGI | 24.99 | 30.1 | 20% | 34.19 |
We realize that there has been a significant amount of press lately regarding potential pricing pressure from hospital administrators towards these orthopedic companies. We agree that it is unlikely that these manufacturers will be able to continue to increase their prices 3-5% a year like they have in the recent past. But we don't believe this will be the downfall of the orthopedic sector. Lets examine how orthopedic companies have increased their average selling prices (not their list prices) during the last several years.
The chart from Orthopedic Network News clearly shows that between 1991-2000 implant average selling prices declined each year. That's 10 years of declining prices. You know what, the public orthopedic sector didn't crumble.
In fact, Biomet stock produced a 25% CAGR during this time period and an 11x return on investment and Stryker's stock produced a 35% CAGR and a 27x return on investment. (These were the only two companies out of the above that were public during that time).